All PlansAdministrativeLow impact
Biosimilars
Blue Cross Blue Shield of Rhode Island·RI · Rheumatology, Gastroenterology, Oncology +2 more·Physician / Facility
Effective date
Jan 1, 2023
We identified it
Jun 19, 2026
Summary
BCBS Rhode Island has provided educational resources about biosimilars, including FDA infographics and continuing education courses for healthcare providers. This is informational content to help providers educate patients about biologics and biosimilars, with no billing or coverage changes specified.
Action Required
Optional: Providers may access free FDA continuing education courses about biosimilars at their discretion to improve patient education. Contact ProviderRelations@bcbsri.org with questions about biosimilars.